For two decades, Dr. Spangler, the Innovation and Value Initiative’s (IVI) Chief Executive Officer, has worked in the professional health policy and public health sectors with pharmaceutical and non-profit organizations. A board certified preventive medicine physician, Dr. Spangler joined IVI from his most recent role as Executive Medical Director and Head of Global HTA Policy Strategy & Engagement for Amgen, Inc. With additional experience as Chief Medical Officer at Partnership for Prevention and as Public Health and Health Policy Consultant at Pfizer, Dr. Spangler has been committed to advancing public health, preventive medicine, healthcare quality, and health equity and has served on multiple councils/committees of both national quality organizations and organizations assessing healthcare value.